News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OccuLogix Inc. (OCCX) Submits 510(k) Premarket Notification for the Tearlab(TM) Osmolarity System


10/29/2008 9:36:04 AM

TORONTO, ONTARIO--(Marketwire - October 29, 2008) - OccuLogix, Inc. (NASDAQ: OCCXD)(TSX: OC) announced today that its subsidiary, OcuSense, Inc., has submitted its 510(k) premarket notification to the US Food and Drug Administration (the FDA) for clearance to market the TearLabâ„¢ Osmolarity System and the TearLabâ„¢ Osmolarity Test Card in the United States.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES